Bezafibrate for Primary Biliary Cholangitis: a Number Needed to Treat Analysis. Journal Abstract - Guideline Central

Bezafibrate for Primary Biliary Cholangitis: a Number Needed to Treat Analysis.

Published: 2026 Jun 10

Authors

, , , , ,

Abstract

The clinical benefit of bezafibrate (BZF) in primary biliary cholangitis (PBC) has not been extensively reported in absolute measures. We assessed the number needed to treat (NNT) with BZF to prevent liver transplantation (LT) or (liver-related) death among people with PBC.

Keywords: Number Need to Treat, Primary Biliary Cholangitis, Second-line Therapy

Source

JHEP reports : innovation in hepatology

Publication Type

Journal Article

Language

English

PubMed ID

42269833

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.